Profilo
Taylor Boyd is Chief Business Officer at Avalo Therapeutics, Inc. since 2025.
Former roles include Chief Business Officer & Executive VP at Abzena Ltd. and Investor Relations Contact at Oxford Biomedica Plc from 2022 to 2024.
Education includes graduate studies at Wake Forest University and undergraduate studies at North Carolina State University.
Posizioni attive di Taylor Boyd
| Società | Posizione | Inizio |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2025 |
Precedenti posizioni note di Taylor Boyd
| Società | Posizione | Fine |
|---|---|---|
| OXFORD BIOMEDICA PLC | Public Communications Contact | 01/01/2024 |
| ABZENA PLC | Corporate Officer/Principal | - |
Formazione di Taylor Boyd
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Oxford Biomedica Plc
Oxford Biomedica Plc BiotechnologyHealth Technology Operates as a contract development and manufacturing organization which provides viral vectors to pharmaceutical and biotechnology clients in cell and gene therapy fields | Health Technology |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Abzena Ltd.
Abzena Ltd. BiotechnologyHealth Technology Engages in discovery, development and manufactures biologics drugs | Health Technology |
















